top of page
Browse by category
Search
Ingestible capsule pumps drugs directly into the walls of the GI tract
Massachusetts Institute of Technology (MIT) and Novo Nordisk researchers have developed an ingestible capsule that releases a burst of...
Tracking leptin pulse patterns offers a potential clue to understanding obesity
Researchers at NYU Tandon School of Engineering have utilised a probabilistic physiological modelling approach to investigate the pulse...
ESSENCE trial: Semaglutide 2.4mg demonstrates statistically significant and superior improvements with in people with MASH
Results from part 1 of the ongoing Phase 3 ESSENCE trial - evaluating the effect of once-weekly subcutaneous semaglutide 2.4mg on liver...
RESET: Epitomee's drug-free oral hydrogel capsule reduces TBW by at least 5% at 24 weeks
Epitomee Medical has reported that outcomes from the RESET study have revealed the total body weight for patients who received the...
GT Metabolic Solutions carries out the first magnetic compression anastomosis cases in the US with the linear magnet technology - the MagDI System
GT Metabolic Solutions has completed the first magnetic compression anastomosis cases in the US using the MagDI System, the procedures...
Journal Watch 20/11/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Coffee time with Mr Abuchi Okaro
Bariatric News spoke to the current President of Bariatric, Metabolic Surgeons Society of Nigeria (BMSSN), Mr Abuchi Okaro (a consultant...
MyPhenome test can predict future weight gain
Phenomix Sciences has announced the findings from new research conducted at Mayo Clinic and presented at ObesityWeek 2024, which...
GLP-1 RAs show cardiovascular benefits beyond weight loss
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) continue to show cardiovascular benefits beyond weight loss, according to several...
GLP-1 RAs may be effective in helping people drink less alcohol
A study led by researchers at the University of Nottingham has found that glucagon-like peptide-1 receptor agonists use (GLP-1 RAs) may...
Browse by tag
bottom of page